The event organizers selected Raleigh for their inaugural event given the Triangle region’s reputation for being an important ...

Durham-based Humacyte, founded by three female scientists in 2004, has received marketing approval from the U.S. Food and ...

This free event will showcase North Carolina’s biologics and pharmaceutical (biopharma) manufacturing educational and career opportunities statewide. Hear from a panel of recent grads who have ...

Oncurie Inc., an RTP company specializing in radiopharmaceuticals and radioisotope chelators for cancer diagnosis and treatment, has been awarded a $349,000 Small Business Technology Transfer (STTR) ...

In the spirit of the holiday season, I’d like to reflect upon my time as the Regional Economic Competitiveness Officer (RECO) for North Carolina’s Build Back Better Regional Challenge (BBBRC), offer ...

An Asheville specialty pharmaceutical company is working to transform a century-old medical procedure into a treatment for migraine relief that patients can easily perform at home. Olfax Medical has ...

North Carolina’s Research Triangle region is the nation’s fourth leading hub for biotechnology activity, trailing only Boston, San Francisco and San Diego, says Fierce Biotech, an online publication ...

Bamboo Therapeutics, a next-generation gene therapy company based in Chapel Hill, has been acquired by the pharmaceutical giant Pfizer of New York. Pfizer, which had acquired a 22 percent stake in ...

Pancreatic cancer is an elusive and deadly disease. It often has no initial symptoms, and there are no reliable tests for early detection. The mortality rate is 75 percent within a year of diagnosis, ...

NCBiotech’s offices will be closed on Dec. 24-26, 2024 and Jan. 1, 2025 for the holidays. Also, the Conference Center at NCBiotech will be closed on Dec. 23 and Dec. 27, 2024.